Merck & Co., Inc. Sees Significant Shareholder Shifts Amid Optimism for Future Prospects
Merck & Co., Inc. (NYSE:MRK) has seen significant changes in its shareholder base over the past few months. In a recent filing with the Securities and Exchange Commission, it was revealed that AMG National Trust Bank reduced its holdings in Merck & Co., Inc. by 54.6% during the second quarter. The institutional investor owned 42,236 shares of the company's stock after selling 50,868 shares during the quarter.
The value of AMG National Trust Bank's holdings in Merck & Co., Inc. was $5,427,000 at the end of the most recent quarter. This reduction in holdings is part of a larger trend of changes to shareholder positions in the company. Several other hedge funds and institutional investors have made significant changes to their stakes in Merck & Co., Inc. over the past few months.
In related news, two executive vice presidents at Merck & Co., Inc. sold shares of the stock in recent transactions. EVP Richard R. Deluca sold 20,784 shares on August 10th for an average price of $130.43 per share, while EVP Chirfi Guindo sold 15,000 shares on August 6th at an average price of $131.00 per share.